Nebenwirkungen · Replagal
Replagal 1 mg/ml concentrate for solution for infusion. · Abschnitt 4.8 · PDF-Seite 6–7
HOS-109152 · Präparat HOS-093103
Infusion related reactions reported in the post-marketing setting (also see section 4.4) may include cardiac events such as cardiac arrhythmias (atrial fibrillation, ventricular extrasystoles, tachyarrhythmia), myocardial ischemia, and heart failure in patients with Fabry disease involving the heart structures. The most common infusion related reactions were mild and include rigors, pyrexia, 6 flushing, headache, nausea, dyspnoea, tremor, and pruritus. Infusion-related symptoms may also include dizziness, hyperhidrosis, hypotension, cough, vomiting and fatigue. Hypersensitivity, including anaphylaxis, has been reported.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-12-19T11:02:00Z · SHA-256 dcaf8d70406379842b10712a63f58455ab2c0f96e49a183cadc2b152a7bb72f1 · Passage 8741664f1749db430f81da520a41bffbf98d9d2cacb00a0cc906aae9f32a46ad · Zeichen 4827–5505 im Abschnitt